Hammad TA - Search Results

1

Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action.

Neilan TG, Rothenberg ML, Amiri-Kordestani L, Sullivan RJ, Steingart RM, Gregory W, Hariharan S, Hammad TA, Lindenfeld J, Murphy MJ, Moslehi JJ; Checkpoint Inhibitor Safety Working Group. Neilan TG, et al. Among authors: hammad ta. Oncologist. 2018 Aug;23(8):874-878. doi: 10.1634/theoncologist.2018-0157. Epub 2018 May 25. Oncologist. 2018. PMID: 29802220 Free PMC article.

2

Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.

Margulis AV, Abou-Ali A, Strazzeri MM, Ding Y, Kuyateh F, Frimpong EY, Levenson MS, Hammad TA. Margulis AV, et al. Among authors: hammad ta. Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):942-51. doi: 10.1002/pds.3462. Epub 2013 Jun 3. Pharmacoepidemiol Drug Saf. 2013. PMID: 23733623

3

Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.

Mosholder AD, Gelperin K, Hammad TA, Phelan K, Johann-Liang R. Mosholder AD, et al. Among authors: hammad ta. Pediatrics. 2009 Feb;123(2):611-6. doi: 10.1542/peds.2008-0185. Pediatrics. 2009. PMID: 19171629 Review.

4

The future of population-based postmarket drug risk assessment: a regulator's perspective.

Hammad TA, Neyarapally GA, Iyasu S, Staffa JA, Dal Pan G. Hammad TA, et al. Clin Pharmacol Ther. 2013 Sep;94(3):349-58. doi: 10.1038/clpt.2013.118. Epub 2013 Jun 5. Clin Pharmacol Ther. 2013. PMID: 23739537

5

Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.

Hammad TA, Neyarapally GA, Pinheiro SP, Iyasu S, Rochester G, Dal Pan G. Hammad TA, et al. Clin Trials. 2013;10(3):389-97. doi: 10.1177/1740774513479467. Epub 2013 Mar 18. Clin Trials. 2013. PMID: 23508987 Review.

6

Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs.

Hammad TA, Graham DJ, Staffa JA, Kornegay CJ, Dal Pan GJ. Hammad TA, et al. Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):315-21. doi: 10.1002/pds.1560. Pharmacoepidemiol Drug Saf. 2008. PMID: 18302311

7

Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.

Hammad TA, Pinheiro SP, Neyarapally GA. Hammad TA, et al. Clin Trials. 2011 Oct;8(5):559-70. doi: 10.1177/1740774511419165. Epub 2011 Aug 30. Clin Trials. 2011. PMID: 21878445 Review.

8

Drug risk assessment and data reuse.

Iyasu S, Staffa J, Graham D, Shoaibi A, Levenson M, Chakravarty A, Hammad TA. Iyasu S, et al. Among authors: hammad ta. Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):107-8. doi: 10.1002/pds.3518. Pharmacoepidemiol Drug Saf. 2014. PMID: 24395549 No abstract available.

9

Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink.

Hammad TA, Margulis AV, Ding Y, Strazzeri MM, Epperly H. Hammad TA, et al. Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1233-8. doi: 10.1002/pds.3511. Epub 2013 Sep 3. Pharmacoepidemiol Drug Saf. 2013. PMID: 24002995

10

Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort.

Margulis AV, Kang EM, Hammad TA. Margulis AV, et al. Among authors: hammad ta. Matern Child Health J. 2014 Sep;18(7):1742-52. doi: 10.1007/s10995-013-1419-2. Matern Child Health J. 2014. PMID: 24374729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page